SCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES. Trademark

Trademark Overview

On Wednesday, April 15, 2020, a trademark application was filed for SCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES. with the United States Patent and Trademark Office. The USPTO has given the SCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES. trademark a serial number of 88873539. The federal status of this trademark filing is REGISTERED as of Tuesday, January 11, 2022. This trademark is owned by Scienture Inc.. The SCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Identifying and developing of innovative technology-based concepts for creating pharmaceutical products; Pharmaceutical research and development (R and D) providing medical and therapeutic research and development in multiple therapeutic areas in particular Central Nervous System (CNS), Cardiovascular System (CVS) and Oncology
scienture prioritizing patients. improving outcomes.

General Information

Serial Number88873539
Word MarkSCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES.
Filing DateWednesday, April 15, 2020
Status700 - REGISTERED
Status DateTuesday, January 11, 2022
Registration Number6610590
Registration DateTuesday, January 11, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Description of MarkThe mark consists of circular designs forming a square shape to the left of the word "scienture" in larger font above the words "Prioritizing Patients. Improving Outcomes." in smaller font.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesIdentifying and developing of innovative technology-based concepts for creating pharmaceutical products; Pharmaceutical research and development (R and D) providing medical and therapeutic research and development in multiple therapeutic areas in particular Central Nervous System (CNS), Cardiovascular System (CVS) and Oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 23, 2020
Primary Code042
First Use Anywhere DateFriday, January 31, 2020
First Use In Commerce DateFriday, January 31, 2020

Trademark Owner History

Party NameSCIENTURE, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressCOMMACK, NY 11725
Party NameScienture Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCommack, NY 11725
Party NameScienture Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHauppauge, NY 11788
Party NameScienture Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHauppauge, NY 11788

Trademark Events

Event DateEvent Description
Saturday, April 18, 2020NEW APPLICATION ENTERED
Thursday, April 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 24, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 6, 2020ASSIGNED TO EXAMINER
Monday, July 13, 2020NON-FINAL ACTION WRITTEN
Monday, July 13, 2020NON-FINAL ACTION E-MAILED
Monday, July 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 29, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, January 29, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, February 1, 2021PETITION TO REVIVE-GRANTED
Monday, February 1, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, February 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 2, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, May 12, 2021ASSIGNED TO LIE
Friday, May 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 23, 2021FINAL REFUSAL WRITTEN
Wednesday, June 23, 2021FINAL REFUSAL E-MAILED
Wednesday, June 23, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 8, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, September 20, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 20, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 20, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 27, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

outcomes improving patients prioritizing scienture research therapeutic system pharmaceutical development central particular areas nervous developing